- Home
- VNDA vs MXF Comparison
VNDA vs MXF Comparison
Compare VNDA & MXF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- MXF
- Stock Information
- Founded
- VNDA 2002
- MXF 1981
- Country
- VNDA United States
- MXF Mexico
- Employees
- VNDA N/A
- MXF N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- MXF Trusts Except Educational Religious and Charitable
- Sector
- VNDA Health Care
- MXF Finance
- Exchange
- VNDA Nasdaq
- MXF Nasdaq
- Market Cap
- VNDA 261.7M
- MXF 239.1M
- IPO Year
- VNDA 2006
- MXF N/A
- Fundamental
- Price
- VNDA $4.78
- MXF $17.35
- Analyst Decision
- VNDA Strong Buy
- MXF
- Analyst Count
- VNDA 3
- MXF 0
- Target Price
- VNDA $15.33
- MXF N/A
- AVG Volume (30 Days)
- VNDA 408.4K
- MXF 27.4K
- Earning Date
- VNDA 07-30-2025
- MXF 01-01-0001
- Dividend Yield
- VNDA N/A
- MXF 4.70%
- EPS Growth
- VNDA N/A
- MXF N/A
- EPS
- VNDA N/A
- MXF N/A
- Revenue
- VNDA $201,351,000.00
- MXF N/A
- Revenue This Year
- VNDA $16.86
- MXF N/A
- Revenue Next Year
- VNDA $39.78
- MXF N/A
- P/E Ratio
- VNDA N/A
- MXF N/A
- Revenue Growth
- VNDA 13.37
- MXF N/A
- 52 Week Low
- VNDA $3.81
- MXF $14.77
- 52 Week High
- VNDA $6.37
- MXF $19.49
- Technical
- Relative Strength Index (RSI)
- VNDA 53.88
- MXF 55.72
- Support Level
- VNDA $4.85
- MXF $17.41
- Resistance Level
- VNDA $5.12
- MXF $17.94
- Average True Range (ATR)
- VNDA 0.18
- MXF 0.23
- MACD
- VNDA 0.01
- MXF -0.03
- Stochastic Oscillator
- VNDA 54.05
- MXF 62.25
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About MXF Mexico Fund Inc. (The)
Mexico Fund Inc is a United States-based non-diversified, closed-end management investment company. Its investment objective is to seek long-term capital appreciation. The fund seeks to achieve its objective through investment in securities, primary in equity, listed on the Mexican Stock Exchange. The company's portfolio of investments consists of investments in different sectors such as auto parts, airports, building materials, chemical products, consumer products, energy, food, and other sectors. The fund provides a vehicle to investors who wish to invest in Mexican companies through a managed non-diversified portfolio as part of their overall investment program.